GNS Healthcare Chosen to Present Discovery of New Clinical Predictors of Overall Survival in Metastatic Colorectal Cancer at ESMO 2019 in Collaboration with the Alliance for Clinical Trials in Oncology

[In The News]

CAMBRIDGE, Mass., July 2, 2019 /PRNewswire/ -- GNS Healthcare (GNS), a leading precision medicine company, together with the Alliance for Clinical Trials in Oncology (Alliance), is presenting discoveries of predictive biomarkers for metastatic colorectal cancer (mCRC) patient response to...

View the full article